AGP Picks
View all

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on September 3, 2026

Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide…
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
Bone Biologics to Participate in the  H.C. Wainwright 28th Annual Global Investment Conference
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
Adneuris Therapeutics to Present at PAINWeek 2026
Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Claris Bio to Participate in Upcoming Investor Conferences
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
Priothera Appoints Experienced Biotech Executive, Dr Nigel Clark, as Chief Business Officer to Lead Strategic Partnering for Mocravimod
Tangram Therapeutics Announces Progression to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial of TGM-312 and Appointment of Dr Sonya Montgomery as Chief Development Officer
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Clene to Present at Upcoming September Investor Conferences

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.